Stock listing

HELP Stock Price, News, Filings & Events — Cybin, Inc.

Selected listing: HELP · NASDAQ · USD · US

This page tracks Cybin, Inc.'s HELP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HELP:NASDAQ. HELP:NASDAQ is the stock-level entry point for investors researching Cybin, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cybin, Inc. is a public company trading under the ticker HELP on the Canadian market. With a market capitalization of approximately $1.36 million, Cybin focuses on developing innovative therapies in the psychedelic sector. The company is committed to advancing its research and development efforts to address mental health challenges.

HELP:NASDAQUSDUSUpdated August 15, 2026
Cybin, Inc. logo
Ticker
HELP:NASDAQ
Asset type
Stock
Market cap
$1.4M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Cybin, Inc. HELP:NASDAQ stock context

This page tracks Cybin, Inc.'s HELP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HELP:NASDAQ. HELP:NASDAQ is the stock-level entry point for investors researching Cybin, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cybin, Inc. is a public company trading under the ticker HELP on the Canadian market. With a market capitalization of approximately $1.36 million, Cybin focuses on developing innovative therapies in the psychedelic sector. The company is committed to advancing its research and development efforts to address mental health challenges.

Research Cybin, Inc.

Alternate listings